Golden has been acquired by ComplyAdvantage.Read about it here ⟶

Viracta Therapeutics

Viracta Therapeutics

Viral activation therapy

Overview Structured Data Issues Contributors Activity

Is a

Company attributes

Industry

Biomedical engineering

0

Location

Cardiff-by-the-Sea, Encinitas, California

0

CEO

0

Pitchbook URL

pitchbook.com/profiles...150408-73

Legal Name

Viracta Therapeutics, Inc.0

Legal classification

0

Number of Employees (Ranges)

11 – 50

Email Address

info@viracta.com0

Phone Number

+185840084700

Number of Employees

280

Full Address

2533 S. Coast Hwy 101, Suite 210, Cardiff, CA 92007, USA0

CIK Number

Place of Incorporation

0

Investors

Forward Ventures

Wicklow Capital

Latterell Venture Partners

DeNovo Ventures

IRS Number

943,295,8780

Total Funding Amount (USD)

83,399,999

Latest Funding Round Date

December 2020

Stock Symbol

VIRX0

Exchange

0

Board of Directors

0

0

Thomas E. Darcy

0

Roger Pomerantz

0

0

Flavia Borellini

0

0

0

CFO

0

Former CEO

0

Latest Funding Type

NAICS Code

325,4120

COO

0

Country

0

Other attributes

Company Operating Status

Active

Contact Page URL

viracta.com/contact/

Previous Name

SUNESIS PHARMACEUTICALS INC0

SIC Code

2,8340

Ticker Symbol

VIRX0

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like Viracta Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Golden Query Tool